29
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Progression of Kidney Disease Varies Between Families with Defects in the Polycystic Kidney Disease Type 1 Gene in Eastern Finland

, , , , , , & show all
Pages 352-358 | Published online: 09 Jul 2009

References

  • Iglesias CG, Torres VE, Offord KP, Holley KE, Beard CM, Kurland LT. Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980. Am J Kidney Dis 1983; 2: 630–9.
  • Reeders ST, Breuning MH, Davies KE, Nicholls RD, Jarman AP, Higgs DR, et al. A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16. Nature 1985; 317: 542–4.
  • The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. The European Polycystic Kidney Disease Consortium. Cell 1994; 77: 881–94.
  • Breuning MH, Reeders ST, Brunner H, Edo JW, Saris JJ, Verwest A, et al. Improved early diagnosis of adult polycystic kidney disease with flanking DNA markers. Lancet 1987; ii: 1359–61.
  • Kimberling WJ, Fain PR, Kenyon JB, Goldgar D, Sujansky E, Gabow PA. Linkage heterogeneity of autosomal dominant polycystic kidney disease. N Engl J Med 1988; 319: 913–8.
  • Wright AF, Teague PW, Pound SE, Pignatelli PM, Macnicol AM, Carothers AD, et al. A study of genetic linkage heterogeneity in 35 adult-onset polycystic kidney disease families. Hum Genet 1993; 90: 569–71.
  • Peters DJ, Sandkuij1 LA. Genetic heterogeneity of polycystic kidney disease in Europe. Contrib Nephrol 1992; 97: 128–39.
  • Peters DJ, Spruit L, Saris JJ, Ravine D, Sandkuij1 LA, Fossdal R, et al. Chromosome 4 localization of a second gene for autosomal dominant polycystic kidney disease. Nat Genet 1993; 5: 359–62.
  • Kimberling WJ, Kumar S, Gabow PA, Kenyon JB, Connolly CJ, Somlo S. Autosomal dominant polycystic kidney disease: localization of the second gene to chromosome 4q13-q23. Genomics 1993; 18: 467–72.
  • Daoust MC, Reynolds DM, Bichet DG, Somlo S. Evidence for a third genetic locus for autosomal dominant polycystic kidney disease. Genomics 1995; 25: 733–6.
  • de Almeida S, de Almeida E, Peters D, Pinto JR, Tavora I, Lavinha J, et al. Autosomal dominant polycystic kidney disease: evidence for the existence of a third locus in a Portuguese family. Hum Genet 1995; 96: 83–8.
  • Hateboer N, Dijk MA, Bogdanova N, Coto E, Saggar-Malik AK, San Millan JL, et al. Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet 1999; 353: 103–7.
  • Torra R, Badenas C, Darnell A, Nicolau C, Volpini V. Revert L, et al. Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2. J Am Soc Nephrol 1996; 7: 2142–51.
  • Milutinovic J, Fialkow PJ, Agodoa LY, Phillips LA, Rudd TG, Sutherland S. Clinical manifestations of autosomal dominant polycystic kidney disease in patients older than 50 years. Am J Kidney Dis 1990; 15: 237–43.
  • Gabow PA, Kaehny WD, Johnson AM, Duley IT, Manco-Johnson M, Lezotte DC, et al. The clinical utility of renal concentrating capacity in polycystic kidney disease. Kidney Int 1989; 35: 675–80.
  • Schwab SJ, Bander SJ, Klahr S. Renal infection in autosomal dominant polycystic kidney disease. Am J Med 1987; 82: 714–8.
  • Gabow PA, Duley I, Johnson AM. Clinical profiles of gross hematuria in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1992; 20: 140–3.
  • Chapman AB, Johnson AM, Gabow PA, Schrier RW. Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1994; 5: 1349–54.
  • Everson GT. Hepatic cysts in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1993; 22: 520–5.
  • Chapman AB, Rubinstein D, Hughes R, Stears JC, Earnest MP, Johnson AM, et al. Intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med 1992; 327: 916–20.
  • Hossack KF, Leddy CL, Johnson AM, Schrier RW, Gabow PA. Echocardiographic findings in autosomal dominant polycystic kidney disease. N Engl J Med 1988; 319: 907–12.
  • Demetriou K, Tziakouri C, Anninou K, Eleftheriou A, Koptides M, Nicolaou A, et al. Autosomal dominant polycystic kidney disease-type 2. Ultrasound, genetic and clinical correlations. Nephrol Dial Transplant 2000; 15: 205–11.
  • de la Chapelle A, Wright FA. Linkage disequilibrium mapping in isolated populations: the example of Finland revisited. Proc Natl Acad Sci U S A 1998; 95: 12416–23.
  • WHO/ISH Guidelines Sub-Committee. 1993 Guideline for the management of mild hypertension: memorandum from World Health Organization/International Society of Hypertension Meeting Highlights of 1993 Guidelines. J Hypertens 1993; 11: 905–18.
  • San Millan JL, Viribay M, Peral B, Martinez I, Weissenbach J, Moreno F. Refining the localization of the PKD2 locus on chromosome 4q by linkage analysis in Spanish families with autosomal dominant polycystic kidney disease type 2. Am J Hum Genet 1995; 56: 248–53.
  • Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P. et al. The 1993–94 Genethon human genetic linkage map [see comments]. Nat Genet 1994; 7(2 Spec No): 246–339.
  • Peral B, Ward CJ, San Millan JL, Thomas S, Stallings RL, Moreno F, et al. Evidence of linkage disequilibrium in the Spanish polycystic kidney disease I population. Am J Hum Genet 1994; 54: 899–908.
  • Deltas CC, Christodoulou K, Tjakouri C, Pierides A. Presymptomatic molecular diagnosis of autosomal dominant polycystic kidney disease using PKD1- and PKD2-linked markers in Cypriot families. Clin Genet 1996; 50: 10–18.
  • Bear JC, McManamon P, Morgan J, Payne RH, Lewis H, Gault MH, et al. Age at clinical onset and at ultrasono-graphic detection of adult polycystic kidney disease: data for genetic counselling. Am J Med Genet 1984; 18: 45–53.
  • Chantler C, Garnett ES, Parsons V, Veall N. Glomerular filtration rate measurement in man by the single injection methods using 51Cr-EDTA. Clin Sci 1969; 37: 169–80.
  • Granerus G, Aurell M. Reference values for 51Cr-EDTA in autosomal dominant clearance as a measure of glomerular filtration rate. Scand J Clin Lab Invest 1981; 41: 611–6.
  • Hateboer N, Lazarou LP, Williams AJ, Holmans P. Ravine D. Familial phenotype differences in PKD11. Kidney Int 1999; 56: 34–40.
  • Fossdal R, Bothvarsson M, Asmundsson P. Ragnarsson J, Peters D, Breuning MH, et al. Icelandic families with autosomal dominant polycystic kidney disease: families unlinked to chromosome 16p13.3 revealed by linkage analysis. Hum Genet 1993; 91: 609–13.
  • Gabow PA, Johnson AM, Kaehny WD, Manco-Johnson ML, Duley IT, Everson GT. Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology 1990; 11: 1033–7.
  • Perrone RD. Extrarenal manifestations of ADPKD. Kidney Int 1997; 51: 2022–36.
  • van Dijk MA, Chang PC, Peters DJ, Breuning MH. Intracranial aneurysms in polycystic kidney disease linked to chromosome 4. J Am Soc Nephrol 1995; 6: 1670–3.
  • Roscoe JM, Brissenden JE, Williams EA, Chery AL, Silverman M. Autosomal dominant polycystic kidney disease in Toronto. Kidney Int 1993; 44: 1101–8.
  • Schwab SJ, Bander SJ, Klahr S. Renal infection in autosomal dominant polycystic kidney disease. Am J Med 1987; 82: 714–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.